Sandbox Reserved 426
From Proteopedia
(Difference between revisions)
(→Overall Structure) |
(→Introduction) |
||
| Line 6: | Line 6: | ||
===Introduction=== | ===Introduction=== | ||
| + | Sickle Cell Disease (SCD) is the result of a single point mutation in Hemoglobin | ||
| + | Beta Glu6 is replaced by Beta Val6 | ||
| + | |||
| + | |||
| + | |||
| + | |||
| + | |||
<Structure load='1qxd' size='500' frame='true' align='right' caption='Insert caption here' scene='Insert optional scene name here' />===Overall Structure=== | <Structure load='1qxd' size='500' frame='true' align='right' caption='Insert caption here' scene='Insert optional scene name here' />===Overall Structure=== | ||
Revision as of 16:43, 4 March 2012
| This Sandbox is Reserved from January 19, 2016, through August 31, 2016 for use for Proteopedia Team Projects by the class Chemistry 423 Biochemistry for Chemists taught by Lynmarie K Thompson at University of Massachusetts Amherst, USA. This reservation includes Sandbox Reserved 425 through Sandbox Reserved 439. |
Contents |
YourMacromolecule
Introduction
Sickle Cell Disease (SCD) is the result of a single point mutation in Hemoglobin Beta Glu6 is replaced by Beta Val6
|
Binding Interactions
Additional Features
Credits
Introduction - name of team member
Overall Structure - name of team member
Drug Binding Site - name of team member
Additional Features - name of team member
